Femoral nerve blocks for acute postoperative pain after knee replacement surgery

Ee-Yuee Chan, Marlene Fransen, David A Parker, Pryseley N Assam, Nelson Chua, Ee-Yuee Chan, Marlene Fransen, David A Parker, Pryseley N Assam, Nelson Chua

Abstract

Background: Total knee replacement (TKR) is a common and often painful operation. Femoral nerve block (FNB) is frequently used for postoperative analgesia.

Objectives: To evaluate the benefits and risks of FNB used as a postoperative analgesic technique relative to other analgesic techniques among adults undergoing TKR.

Search methods: We searched the Cochrane Central Register of Controlled Trials (CENTRAL) 2013, Issue 1, MEDLINE, EMBASE, CINAHL, Web of Science, dissertation abstracts and reference lists of included studies. The date of the last search was 31 January 2013.

Selection criteria: We included randomized controlled trials (RCTs) comparing FNB with no FNB (intravenous patient-controlled analgesia (PCA) opioid, epidural analgesia, local infiltration analgesia, and oral analgesia) in adults after TKR. We also included RCTs that compared continuous versus single-shot FNB.

Data collection and analysis: Two review authors independently performed study selection and data extraction. We undertook meta-analysis (random-effects model) and used relative risk ratios (RRs) for dichotomous outcomes and mean differences (MDs) or standardized mean differences (SMDs) for continuous outcomes. We interpreted SMDs according to rule of thumb where 0.2 or smaller represents a small effect, 0.5 a moderate effect and 0.8 or larger, a large effect.

Main results: We included 45 eligible RCTs (2710 participants) from 47 publications; 20 RCTs had more than two allocation groups. A total of 29 RCTs compared FNB (with or without concurrent treatments including PCA opioid) versus PCA opioid, 10 RCTs compared FNB versus epidural, five RCTs compared FNB versus local infiltration analgesia, one RCT compared FNB versus oral analgesia and four RCTs compared continuous versus single-shot FNB. Most included RCTs were rated as low or unclear risk of bias for the aspects rated in the risk of bias assessment tool, except for the aspect of blinding. We rated 14 (31%) RCTs at high risk for both participant and assessor blinding and rated eight (18%) RCTs at high risk for one blinding aspect.Pain at rest and pain on movement were less for FNB (of any type) with or without a concurrent PCA opioid compared with PCA opioid alone during the first 72 hours post operation. Pooled results demonstrated a moderate effect of FNB for pain at rest at 24 hours (19 RCTs, 1066 participants, SMD -0.72, 95% CI -0.93 to -0.51, moderate-quality evidence) and a moderate to large effect for pain on movement at 24 hours (17 RCTs, 1017 participants, SMD -0.94, 95% CI -1.32 to -0.55, moderate-quality evidence). Pain was also less in each FNB subgroup: single-shot FNB, continuous FNB and continuous FNB + sciatic block, compared with PCA. FNB also was associated with lower opioid consumption (IV morphine equivalent) at 24 hours (20 RCTs, 1156 participants, MD -14.74 mg, 95% CI -18.68 to -10.81 mg, high-quality evidence) and at 48 hours (MD -14.53 mg, 95% CI -20.03 to -9.02 mg), lower risk of nausea and/or vomiting (RR 0.47, 95% CI 0.33 to 0.68, number needed to treat for an additional harmful outcome (NNTH) four, high-quality evidence), greater knee flexion (11 RCTs, 596 participants, MD 6.48 degrees, 95% CI 4.27 to 8.69 degrees, moderate-quality evidence) and greater patient satisfaction (four RCTs, 180 participants, SMD 1.06, 95% CI 0.74 to 1.38, low-quality evidence) compared with PCA.We could not demonstrate a difference in pain between FNB (any type) and epidural analgesia in the first 72 hours post operation, including pain at 24 hours at rest (six RCTs, 328 participants, SMD -0.05, 95% CI -0.43 to 0.32, moderate-quality evidence) and on movement (six RCTs, 317 participants, SMD 0.01, 95% CI -0.21 to 0.24, high-quality evidence). No difference was noted at 24 hours for opioid consumption (five RCTs, 341 participants, MD -4.35 mg, 95% CI -9.95 to 1.26 mg, high-quality evidence) or knee flexion (six RCTs, 328 participants, MD -1.65, 95% CI -5.14 to 1.84, high-quality evidence). However, FNB demonstrated lower risk of nausea/vomiting (four RCTs, 183 participants, RR 0.63, 95% CI 0.41 to 0.97, NNTH 8, moderate-quality evidence) and higher patient satisfaction (two RCTs, 120 participants, SMD 0.60, 95% CI 0.23 to 0.97, low-quality evidence), compared with epidural analgesia.Pooled results of four studies (216 participants) comparing FNB with local infiltration analgesia detected no difference in analgesic effects between the groups at 24 hours for pain at rest (SMD 0.06, 95% CI -0.61 to 0.72, moderate-quality evidence) or pain on movement (SMD 0.38, 95% CI -0.10 to 0.86, low-quality evidence). Only one included RCT compared FNB with oral analgesia. We considered this evidence insufficient to allow judgement of the effects of FNB compared with oral analgesia.Continuous FNB provided less pain compared with single-shot FNB (four RCTs, 272 participants) at 24 hours at rest (SMD -0.62, 95% CI -1.17 to -0.07, moderate-quality evidence) and on movement (SMD -0.42, 95% CI -0.67 to -0.17, high-quality evidence). Continuous FNB also demonstrated lower opioid consumption compared with single-shot FNB at 24 hours (three RCTs, 236 participants, MD -13.81 mg, 95% CI -23.27 to -4.35 mg, moderate-quality evidence).Generally, the meta-analyses demonstrated considerable statistical heterogeneity, with type of FNB, allocation concealment and blinding of participants, personnel and outcome assessors reducing heterogeneity in the analyses. Available evidence was insufficient to allow determination of the comparative safety of the various analgesic techniques. Few RCTs reported on serious adverse effects such as neurological injury, postoperative falls or thrombotic events.

Authors' conclusions: Following TKR, FNB (with or without concurrent treatments including PCA opioid) provided more effective analgesia than PCA opioid alone, similar analgesia to epidural analgesia and less nausea/vomiting compared with PCA alone or epidural analgesia. The review also found that continuous FNB provided better analgesia compared with single-shot FNB. RCTs were insufficient to allow definitive conclusions on the comparison between FNB and local infiltration analgesia or oral analgesia.

Conflict of interest statement

Ee‐Yuee Chan, Marlene Fransen and Nelson Chua were the study authors of an RCT (Chan 2013) that was eligible for inclusion in this Cochrane review.

Pryseley N Assam is a co‐author of a possible publication arising from the RCT authored by Chan et al (Chan 2013).

David A Parker co‐authored an RCT (Widmer 2012) that was also included in this review.

Figures

1
1
Study flow diagram.
2
2
Risk of bias summary: review authors' judgements about each risk of bias item for each included study.
3
3
Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.
4
4
Forest plot of comparison: 1 FNB versus PCA opioid. Outcome: 1.8 Pain on movement at 24 hours.
5
5
Forest plot of comparison: 2 FNB versus epidural. Outcome: 2.5 Pain on movement at 24 hours.
6
6
Forest plot of comparison: 4 Continuous FNB versus single‐shot FNB. Outcome: 4.5 Pain on movement at 24 hours.
1.1. Analysis
1.1. Analysis
Comparison 1 FNB versus PCA opioid, Outcome 1 Pain at rest first 2 hours.
1.2. Analysis
1.2. Analysis
Comparison 1 FNB versus PCA opioid, Outcome 2 Pain at rest 3 to 12 hours.
1.3. Analysis
1.3. Analysis
Comparison 1 FNB versus PCA opioid, Outcome 3 Pain at rest 24 hours.
1.4. Analysis
1.4. Analysis
Comparison 1 FNB versus PCA opioid, Outcome 4 Pain at rest 48 hours.
1.5. Analysis
1.5. Analysis
Comparison 1 FNB versus PCA opioid, Outcome 5 Pain at rest 72 hours.
1.6. Analysis
1.6. Analysis
Comparison 1 FNB versus PCA opioid, Outcome 6 Pain on movement first 2 hours.
1.7. Analysis
1.7. Analysis
Comparison 1 FNB versus PCA opioid, Outcome 7 Pain on movement 3 to 12 hours.
1.8. Analysis
1.8. Analysis
Comparison 1 FNB versus PCA opioid, Outcome 8 Pain on movement 24 hours.
1.9. Analysis
1.9. Analysis
Comparison 1 FNB versus PCA opioid, Outcome 9 Pain on movement 48 hours.
1.10. Analysis
1.10. Analysis
Comparison 1 FNB versus PCA opioid, Outcome 10 Pain on movement 72 hours.
1.11. Analysis
1.11. Analysis
Comparison 1 FNB versus PCA opioid, Outcome 11 Pain at rest 24 hours—subgrouped by FNB with and without concurrent PCA.
1.12. Analysis
1.12. Analysis
Comparison 1 FNB versus PCA opioid, Outcome 12 Pain on movement 24 hours—subgrouped by FNB with and without concurrent PCA.
1.13. Analysis
1.13. Analysis
Comparison 1 FNB versus PCA opioid, Outcome 13 Pain at rest 24 hours—subgrouped by FNB ropivacaine vs bupivacaine.
1.14. Analysis
1.14. Analysis
Comparison 1 FNB versus PCA opioid, Outcome 14 Pain on movement 24 hours—subgrouped by FNB ropivacaine vs bupivacaine.
1.15. Analysis
1.15. Analysis
Comparison 1 FNB versus PCA opioid, Outcome 15 Pain at rest 24 hours—sensitivity analysis by low bias for allocation concealment.
1.16. Analysis
1.16. Analysis
Comparison 1 FNB versus PCA opioid, Outcome 16 Pain on movement 24 hours—sensitivity analysis by low bias for allocation concealment.
1.17. Analysis
1.17. Analysis
Comparison 1 FNB versus PCA opioid, Outcome 17 Pain on rest 24 hours—sensitivity analysis by blinding of participants, personnel and outcome assessor.
1.18. Analysis
1.18. Analysis
Comparison 1 FNB versus PCA opioid, Outcome 18 Pain on movement 24 hours—sensitivity analysis by blinding of participants, personnel and outcome assessor.
1.19. Analysis
1.19. Analysis
Comparison 1 FNB versus PCA opioid, Outcome 19 Opioid consumption 24 hours (mg).
1.20. Analysis
1.20. Analysis
Comparison 1 FNB versus PCA opioid, Outcome 20 Opioid consumption 48 hours (mg).
1.21. Analysis
1.21. Analysis
Comparison 1 FNB versus PCA opioid, Outcome 21 Nausea and/or vomiting.
1.22. Analysis
1.22. Analysis
Comparison 1 FNB versus PCA opioid, Outcome 22 Sedation.
1.23. Analysis
1.23. Analysis
Comparison 1 FNB versus PCA opioid, Outcome 23 Urinary retention.
1.24. Analysis
1.24. Analysis
Comparison 1 FNB versus PCA opioid, Outcome 24 Knee flexion range of motion (postoperative day 2 to 4).
1.25. Analysis
1.25. Analysis
Comparison 1 FNB versus PCA opioid, Outcome 25 Participant satisfaction with analgesia during hospital stay.
2.1. Analysis
2.1. Analysis
Comparison 2 FNB versus epidural, Outcome 1 Pain at rest first 2 hours.
2.2. Analysis
2.2. Analysis
Comparison 2 FNB versus epidural, Outcome 2 Pain at rest 3 to 12 hours.
2.3. Analysis
2.3. Analysis
Comparison 2 FNB versus epidural, Outcome 3 Pain at rest 24 hours.
2.4. Analysis
2.4. Analysis
Comparison 2 FNB versus epidural, Outcome 4 Pain at rest 48 hours.
2.5. Analysis
2.5. Analysis
Comparison 2 FNB versus epidural, Outcome 5 Pain on movement 24 hours.
2.6. Analysis
2.6. Analysis
Comparison 2 FNB versus epidural, Outcome 6 Pain on movement 48 hours.
2.7. Analysis
2.7. Analysis
Comparison 2 FNB versus epidural, Outcome 7 Pain at rest 24 hours—subgrouped by FNB ropivacaine vs bupivacaine.
2.8. Analysis
2.8. Analysis
Comparison 2 FNB versus epidural, Outcome 8 Pain on movement 24 hours—subgrouped by FNB ropivacaine vs bupivacaine.
2.9. Analysis
2.9. Analysis
Comparison 2 FNB versus epidural, Outcome 9 Pain at rest 24 hours—sensitivity analysis by low bias for allocation concealment.
2.10. Analysis
2.10. Analysis
Comparison 2 FNB versus epidural, Outcome 10 Pain on movement 24 hours—sensitivity analysis by low bias for allocation concealment.
2.11. Analysis
2.11. Analysis
Comparison 2 FNB versus epidural, Outcome 11 Opioid consumption 24 hours (mg).
2.12. Analysis
2.12. Analysis
Comparison 2 FNB versus epidural, Outcome 12 Opioid consumption 48 hours (mg).
2.13. Analysis
2.13. Analysis
Comparison 2 FNB versus epidural, Outcome 13 Nausea and/or vomiting.
3.1. Analysis
3.1. Analysis
Comparison 3 FNB versus local infiltration analgesia, Outcome 1 Pain at rest 24 hours.
3.2. Analysis
3.2. Analysis
Comparison 3 FNB versus local infiltration analgesia, Outcome 2 Pain at rest 48 hours.
3.3. Analysis
3.3. Analysis
Comparison 3 FNB versus local infiltration analgesia, Outcome 3 Pain on movement 24 hours.
3.4. Analysis
3.4. Analysis
Comparison 3 FNB versus local infiltration analgesia, Outcome 4 Pain on movement 48 hours.
3.5. Analysis
3.5. Analysis
Comparison 3 FNB versus local infiltration analgesia, Outcome 5 Nausea and/or vomiting.
4.1. Analysis
4.1. Analysis
Comparison 4 Continuous FNB versus single‐shot FNB, Outcome 1 Pain at rest first 2 hours.
4.2. Analysis
4.2. Analysis
Comparison 4 Continuous FNB versus single‐shot FNB, Outcome 2 Pain at rest 3 to 12 hours.
4.3. Analysis
4.3. Analysis
Comparison 4 Continuous FNB versus single‐shot FNB, Outcome 3 Pain at rest 24 hours.
4.4. Analysis
4.4. Analysis
Comparison 4 Continuous FNB versus single‐shot FNB, Outcome 4 Pain at rest 48 hours.
4.5. Analysis
4.5. Analysis
Comparison 4 Continuous FNB versus single‐shot FNB, Outcome 5 Pain on movement 24 hours.
4.6. Analysis
4.6. Analysis
Comparison 4 Continuous FNB versus single‐shot FNB, Outcome 6 Pain on movement 48 hours.
4.7. Analysis
4.7. Analysis
Comparison 4 Continuous FNB versus single‐shot FNB, Outcome 7 Pain on rest 24 hours—subgrouped by continuous FNB with or without concurrent PCA.
4.8. Analysis
4.8. Analysis
Comparison 4 Continuous FNB versus single‐shot FNB, Outcome 8 Pain on movement 24 hours—subgrouped by continuous FNB with or without concurrent PCA.
4.9. Analysis
4.9. Analysis
Comparison 4 Continuous FNB versus single‐shot FNB, Outcome 9 Pain at rest 24 hours—sensitivity analysis by low bias for allocation concealment.
4.10. Analysis
4.10. Analysis
Comparison 4 Continuous FNB versus single‐shot FNB, Outcome 10 Pain on movement 24 hours—sensitivity analysis by low bias for allocation concealment.
4.11. Analysis
4.11. Analysis
Comparison 4 Continuous FNB versus single‐shot FNB, Outcome 11 Opioid consumption 24 hours (mg).
4.12. Analysis
4.12. Analysis
Comparison 4 Continuous FNB versus single‐shot FNB, Outcome 12 Opioid consumption 48 hours (mg).

Source: PubMed

3
Iratkozz fel